<!DOCTYPE html>
<html>
<head>
	<meta charset="utf-8">
	<meta name="viewport" content="width=device-width, initial-scale=1">
	<title>Lilly Wins Chinese Approval for Tirzepatide in Obesity on Heels of Novoâ€™s Semaglutide | The Freedom  Project</title>

	<meta name="description" content="">

	<!-- Open Graph meta tags (for Facebook, LinkedIn, etc.) -->
	<meta property="og:title" content="Lilly Wins Chinese Approval for Tirzepatide in Obesity on Heels of Novoâ€™s Semaglutide">
	<meta property="og:description" content="">
	<meta property="og:image" content="https://static.biospace.com/dims4/default/2197010/2147483647/strip/true/crop/3870x2177+0+64/resize/1440x810!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F4d%2Fd2%2F49887dc04ae8983e8777d7361d29%2Fistock-2157849824.jpg">
	<meta property="og:url" content="https://www.biospace.com/policy/lilly-wins-chinese-approval-for-tirzepatide-in-obesity-on-heels-of-novos-semaglutide">

	<!-- Twitter Card meta tags (for Twitter) -->
	<meta name="twitter:card" content="https://static.biospace.com/dims4/default/2197010/2147483647/strip/true/crop/3870x2177+0+64/resize/1440x810!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F4d%2Fd2%2F49887dc04ae8983e8777d7361d29%2Fistock-2157849824.jpg">
	<meta name="twitter:title" content="Lilly Wins Chinese Approval for Tirzepatide in Obesity on Heels of Novoâ€™s Semaglutide">
	<meta name="twitter:description" content="">
	<meta name="twitter:image" content="https://static.biospace.com/dims4/default/2197010/2147483647/strip/true/crop/3870x2177+0+64/resize/1440x810!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F4d%2Fd2%2F49887dc04ae8983e8777d7361d29%2Fistock-2157849824.jpg">
	
	<link rel="stylesheet" type="text/css" href="https://cdn.jsdelivr.net/npm/bootstrap@5.3.0/dist/css/bootstrap.min.css">

	<!-- Include Font Awesome CSS -->
	<link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.15.4/css/all.min.css">

	<link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/bootstrap-icons@1.11.3/font/bootstrap-icons.min.css">


	<link rel="preconnect" href="https://fonts.googleapis.com">
	<link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
	<link href="https://fonts.googleapis.com/css2?family=Poppins:ital,wght@0,400;0,500;1,400&family=Roboto:ital,wght@0,100;0,300;0,400;0,500;0,700;0,900;1,100;1,300;1,400;1,500;1,700;1,900&display=swap" rel="stylesheet">
	<link href="https://fonts.googleapis.com/css2?family=Roboto+Condensed&display=swap" rel="stylesheet">

	<link href="https://fonts.googleapis.com/css2?family=Alegreya+Sans:ital,wght@0,100;0,300;0,400;0,500;0,700;0,800;0,900;1,100;1,300;1,400;1,500;1,700;1,800;1,900&display=swap" rel="stylesheet">

	<style>
		.alegreya-sans-thin {
		  font-family: "Alegreya Sans", sans-serif;
		  font-weight: 100;
		  font-style: normal;
		}

		.alegreya-sans-thin-italic {
		  font-family: "Alegreya Sans", sans-serif;
		  font-weight: 100;
		  font-style: italic;
		}

		.alegreya-sans-light {
		  font-family: "Alegreya Sans", sans-serif;
		  font-weight: 300;
		  font-style: normal;
		}

		.alegreya-sans-light-italic {
		  font-family: "Alegreya Sans", sans-serif;
		  font-weight: 300;
		  font-style: italic;
		}

		.alegreya-sans-regular {
		  font-family: "Alegreya Sans", sans-serif;
		  font-weight: 400;
		  font-style: normal;
		}

		.alegreya-sans-regular-italic {
		  font-family: "Alegreya Sans", sans-serif;
		  font-weight: 400;
		  font-style: italic;
		}

		.alegreya-sans-medium {
		  font-family: "Alegreya Sans", sans-serif;
		  font-weight: 500;
		  font-style: normal;
		}

		.alegreya-sans-medium-italic {
		  font-family: "Alegreya Sans", sans-serif;
		  font-weight: 500;
		  font-style: italic;
		}

		.alegreya-sans-bold {
		  font-family: "Alegreya Sans", sans-serif;
		  font-weight: 700;
		  font-style: normal;
		}

		.alegreya-sans-bold-italic {
		  font-family: "Alegreya Sans", sans-serif;
		  font-weight: 700;
		  font-style: italic;
		}

		.alegreya-sans-extrabold {
		  font-family: "Alegreya Sans", sans-serif;
		  font-weight: 800;
		  font-style: normal;
		}

		.alegreya-sans-extrabold-italic {
		  font-family: "Alegreya Sans", sans-serif;
		  font-weight: 800;
		  font-style: italic;
		}

		.alegreya-sans-black {
		  font-family: "Alegreya Sans", sans-serif;
		  font-weight: 900;
		  font-style: normal;
		}

		.alegreya-sans-black-italic {
		  font-family: "Alegreya Sans", sans-serif;
		  font-weight: 900;
		  font-style: italic;
		}


		.roboto-thin {
		  font-family: "Roboto", sans-serif;
		  font-weight: 100;
		  font-style: normal;
		}

		.roboto-light {
		  font-family: "Roboto", sans-serif;
		  font-weight: 300;
		  font-style: normal;
		}

		.roboto-regular {
		  font-family: "Roboto", sans-serif;
		  font-weight: 400;
		  font-style: normal;
		}

		.roboto-medium {
		  font-family: "Roboto", sans-serif;
		  font-weight: 500;
		  font-style: normal;
		}

		.roboto-bold {
		  font-family: "Roboto", sans-serif;
		  font-weight: 700;
		  font-style: normal;
		}

		.roboto-black {
		  font-family: "Roboto", sans-serif;
		  font-weight: 900;
		  font-style: normal;
		}

		.roboto-thin-italic {
		  font-family: "Roboto", sans-serif;
		  font-weight: 100;
		  font-style: italic;
		}

		.roboto-light-italic {
		  font-family: "Roboto", sans-serif;
		  font-weight: 300;
		  font-style: italic;
		}

		.roboto-regular-italic {
		  font-family: "Roboto", sans-serif;
		  font-weight: 400;
		  font-style: italic;
		}

		.roboto-medium-italic {
		  font-family: "Roboto", sans-serif;
		  font-weight: 500;
		  font-style: italic;
		}

		.roboto-bold-italic {
		  font-family: "Roboto", sans-serif;
		  font-weight: 700;
		  font-style: italic;
		}

		.roboto-black-italic {
		  font-family: "Roboto", sans-serif;
		  font-weight: 900;
		  font-style: italic;
		}

		.poppins-regular {
		  font-family: "Poppins", sans-serif;
		  font-weight: 400;
		  font-style: normal;
		}

		.poppins-medium {
		  font-family: "Poppins", sans-serif;
		  font-weight: 500;
		  font-style: normal;
		}

		.poppins-regular-italic {
		  font-family: "Poppins", sans-serif;
		  font-weight: 400;
		  font-style: italic;
		}

		.roboto-condensed-regular {
		  font-family: "Roboto Condensed", sans-serif;
		  font-optical-sizing: auto;
		  font-weight: 400;
		  font-style: normal;
		}

		h1, h2, h3, h4, h5{
		  font-family: "Roboto Condensed", sans-serif;
		  font-optical-sizing: auto;
		  font-weight: 400;
		  font-style: normal;		}
		}

		p{
		  font-family: "Poppins", sans-serif;
		  font-weight: 400;
		  font-style: normal;
		}
	</style>


    <!-- Google tag (gtag.js) -->
    <script async src="https://www.googletagmanager.com/gtag/js?id=G-PPP5N1WD9F"></script>
    <script>
      window.dataLayer = window.dataLayer || [];
      function gtag(){dataLayer.push(arguments);}
      gtag('js', new Date());
    
      gtag('config', 'G-PPP5N1WD9F');
    </script>

</head>
<body>
	<section>
		<!-- As a link -->
		<nav class="navbar navbar-dark bg-dark fixed-top">
		  <div class="container-fluid">
		    <a class="navbar-brand roboto-condensed-regular" href="">The Freedom Project</a>
		  </div>
		</nav>
	</section>

	<section>
		<div class="container">
			<div class="row mt-5">
				<div class="col-12 mt-5 d-flex justify-content-center align-items-center flex-column" id="title-container">
					<h3 class="alegreya-sans-medium text-center">Lilly Wins Chinese Approval for Tirzepatide in Obesity on Heels of Novoâ€™s Semaglutide</h3>
					<!--<p class="roboto-medium text-secondary mb-0">Authors</p>-->
					<!--
						<p class="alegreya-sans-regular mt-0 text-secondary mb-0">By Tristan Manalac, www.biospace.com, tristan-manalac</p>
					--->
					<p class="alegreya-sans-regular mt-0 text-secondary">22 July, 2024</p>

				</div>



				<div class="col-12 mt-2 mb-5 alegreya-sans-light d-flex justify-content-center" id="image-container">
					<img src="https://static.biospace.com/dims4/default/2197010/2147483647/strip/true/crop/3870x2177+0+64/resize/1440x810!/quality/90/?url=https%3A%2F%2Fk1-prod-biospace.s3.us-east-2.amazonaws.com%2Fbrightspot%2F4d%2Fd2%2F49887dc04ae8983e8777d7361d29%2Fistock-2157849824.jpg" class="img-fluid shadow" style="max-height: 280px; object-fit: cover; border-radius: 10px; border: none">
				</div>

				<div class="col-12 mb-3 alegreya-sans-regular" id="secondary-keyword-summary" style="font-size: 18px">
					<div>
                                    <p>China&#8217;s health regulator has signed off on <a class="Link" href="https://www.biospace.com/employer/395010/eli-lilly-and-company" target="_blank" rel="noopener">Eli Lilly</a>&#8217;s top-selling obesity drug tirzepatide for chronic weight management, the pharma announced in a <a class="Link" href="https://mp-weixin-qq-com.translate.goog/s/8D4qauGinkVfSpAmNRdt-Q?_x_tr_sl=auto&amp;_x_tr_tl=en&amp;_x_tr_hl=en&amp;_x_tr_pto=wapp" target="_blank" rel="noopener">social media post</a> on Friday.</p><p>According to Lilly&#8217;s post, tirzepatide is the first and only dual GIP/GLP-1 receptor cleared for obesity treatment in China. The pharma has not yet revealed launch plans for the weight-loss drug, including its projected timeline and expected pricing.</p><p>Tirzepatide has <a class="Link" href="https://www.reuters.com/business/healthcare-pharmaceuticals/eli-lillys-diabetes-drug-tirzepatide-gets-approval-china-2024-05-21/" target="_blank" rel="noopener">previously been approved in China</a> but was specifically indicated for type 2 diabetes.</p><p>&#8220;Currently, more than half of Chinese adults are experiencing the effects of obesity or overweight,&#8221; Huzur Devletsah, president and general manager of Lilly China, said in the statement on social media. Tirzepatide&#8217;s approval in the country &#8220;marks the first long-term weight management innovative drug for Lilly China&#8221; and &#8220;will benefit hundreds of millions of people,&#8221; Devletsah said.</p><p>Tirzepatide&#8217;s Chinese approval is backed by data from the <a class="Link" href="https://www.clinicaltrials.gov/study/NCT05024032" target="_blank" rel="noopener">SURMOUNT-CN trial</a>&#8212;the China arm of Lilly&#8217;s SURMOUNT program&#8212;which is one of the few studies that used body mass index (BMI) cutoffs that were in-line with China&#8217;s diagnostic and treatment guidelines. Instead of applying the typical thresholds of 25 kg/m2 and 30 kg/m2, SURMOUNT-CN defined overweight as having BMI of at least 24 kg/m2, while the cutoff for obesity was 28 kg/m2. All patients also had at least one weight-related comorbidity.</p><p>Results of the study, which were published in the <a class="Link" href="https://jamanetwork.com/journals/jama/article-abstract/2819431" target="_blank" rel="noopener"><i>Journal of the American Medical Association</i></a> earlier this year, showed that at 52 weeks patients dropped an average of 13.6% of their body weight after treatment with the 10 mg dose of tirzepatide. The 15-mg dose had a slightly stronger effect, eliciting 17.5% weight loss. Meanwhile, those patients in the placebo group only lost 2.3% of their weight.</p><p>Tirzepatide was also found to be safe and well-tolerated in the study population, with the most common treatment-emergent adverse events being gastrointestinal in nature and largely mild or moderate in severity. In addition, less than 5% of toxicities led to study dropout.</p><p>Friday&#8217;s Chinese obesity indication for tirzepatide puts Lilly on roughly equal footing with Novo Nordisk. Semaglutide, the pharma&#8217;s blockbuster GLP-1 treatment, was <a class="Link" href="https://www.cnbc.com/2024/06/25/novo-nordisks-wegovy-weight-loss-drug-approved-in-china.html#:~:text=Meanwhile%2C%20clinical%20trial%20records%20show,China%20region%20double%20last%20year." target="_blank" rel="noopener">approved</a> in China for diabetes in 2021 and again <a class="Link" href="https://www.prnasia.com/story/451925-1.shtml" target="_blank" rel="noopener">last month</a> for weight loss.</p> 
                                
                            

                            
                    </div>
				</div>

				<!--<div class="col-12 mb-3 alegreya-sans-light d-flex justify-content-start" id="secondary-keyword-summary">
					<a class="btn btn-dark btn-lg shadow" href='https://www.biospace.com/policy/lilly-wins-chinese-approval-for-tirzepatide-in-obesity-on-heels-of-novos-semaglutide'><div class="d-flex"><p class="me-2 mb-0">Continue Reading</p> <i class="bi bi-arrow-right-circle"></i></div></a>
				</div>-->


				<!--<div class="col-12 mb-4 roboto-condensed-regular mt-4">
					
				</div>-->
			</div>

		</div>
	</section>

	<section id="recentArticlesSection">

	</section>

	<section>
		<div class="row">
			<div class="col-12">
				<div class="d-flex justify-content-center py-1">
						<p class="alegreya-sans-medium text-center ms-2" style="font-size: 18px; color: grey;">The Freedom Project - &copy; <span id="currentYear"></span> ðŸ˜Œ </p>
				</div>
			</div>
		</div>
	</section>

	   <script>
        // Get the current year
        const currentYear = new Date().getFullYear();
        
        // Find the span element with the id 'currentYear'
        const yearElement = document.getElementById('currentYear');
        
        // Set the text content of the span element to the current year
        yearElement.textContent = currentYear;
    </script>

	<!-- Bootstrap Bundle from CDN -->
	<script src="https://cdn.jsdelivr.net/npm/bootstrap@5.3.0/dist/js/bootstrap.bundle.min.js"></script>

	<!-- jQuery from CDN -->
	<script src="https://ajax.googleapis.com/ajax/libs/jquery/3.6.1/jquery.min.js"></script>

	<script type="text/javascript">
		$(function(){
				$.getJSON("https://raw.githubusercontent.com/pdmarc7/thefreedomproject/main/data.json", function(data){
						//console.log(data)

						var randomSelectedArticles = getRandomElements(data, 6)

					$('#recentArticlesSection').append(
						$('<div>').addClass('container').append(
							$('<div>').addClass('row').append(
								$('<div>').addClass('col-12').append(
									$('<p>').addClass('h3 alegreya-sans-medium mb-2').text('Recent international news')
								),

								buildRandomArticleArr(randomSelectedArticles)
							)
						)
					)
				});

				function getRandomElements(arr, n) {
				    // Shuffle array using Fisher-Yates shuffle algorithm
				    for (let i = arr.length - 1; i > 0; i--) {
				        const j = Math.floor(Math.random() * (i + 1));
				        [arr[i], arr[j]] = [arr[j], arr[i]];
				    }

				    // Return the first n elements
				    return arr.slice(0, n);
				}



				function buildArticleCard(article){
					return $('<div>').addClass('card').append(

						$('<img>').attr({
							'src': article["top_image"],
							'alt': ''
						}).addClass('card-img-top'),

						$('<div>').addClass('card-body').append(
							$('<p>').addClass('h5 card-title alegreya-sans-medium').append(`${article.title}`),
							$('<a>').attr({
								'href': `http://${window.location.hostname}:${window.location.port}`+'/'+article.url
							}).addClass("btn btn-dark").append('Read More')
						)
					)
				}

				function buildRandomArticleArr(selectedArticles){
					var articles = []

					for (const n of selectedArticles){
						articles.push(
							$('<div>').addClass('col-12 col-md-4 mb-4').append(
								buildArticleCard(n)
							)
						)
					}

					return articles
				}

		})
	</script>


	<!-- GSAP and ScrollTrigger from CDN -->
	<!--<script src="https://cdn.jsdelivr.net/npm/gsap@3.9.1/dist/gsap.min.js"></script>
	<script src="https://cdn.jsdelivr.net/npm/gsap@3.9.1/dist/ScrollTrigger.min.js"></script>-->
    <script>

    </script>

</body>
</html>